Benitec Biopharma Ltd Stock Alpha and Beta Analysis
| BNTC Stock | USD 11.49 0.58 5.32% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Benitec Biopharma Ltd. It also helps investors analyze the systematic and unsystematic risks associated with investing in Benitec Biopharma over a specified time horizon. Remember, high Benitec Biopharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Benitec Biopharma's market risk premium analysis include:
Beta (0.51) | Alpha 0.12 | Risk 4.46 | Sharpe Ratio 0.0254 | Expected Return 0.11 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Benitec |
Benitec Biopharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Benitec Biopharma market risk premium is the additional return an investor will receive from holding Benitec Biopharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Benitec Biopharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Benitec Biopharma's performance over market.| α | 0.12 | β | -0.51 |
Benitec Biopharma expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Benitec Biopharma's Buy-and-hold return. Our buy-and-hold chart shows how Benitec Biopharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Benitec Biopharma Market Price Analysis
Market price analysis indicators help investors to evaluate how Benitec Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Benitec Biopharma shares will generate the highest return on investment. By understating and applying Benitec Biopharma stock market price indicators, traders can identify Benitec Biopharma position entry and exit signals to maximize returns.
Benitec Biopharma Return and Market Media
The median price of Benitec Biopharma for the period between Sat, Nov 2, 2024 and Fri, Jan 31, 2025 is 10.78 with a coefficient of variation of 7.56. The daily time series for the period is distributed with a sample standard deviation of 0.83, arithmetic mean of 10.98, and mean deviation of 0.65. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Benitec GAAP EPS of -0.48 | 11/14/2024 |
2 | Acquisition by Suvretta Capital Management, Llc of 1570 shares of Benitec Biopharma at 9.73 subject to Rule 16b-3 | 11/19/2024 |
3 | Acquisition by Suvretta Capital Management, Llc of 3076 shares of Benitec Biopharma at 10.22 subject to Rule 16b-3 | 11/20/2024 |
4 | Acquisition by Suvretta Capital Management, Llc of 4810 shares of Benitec Biopharma at 9.6 subject to Rule 16b-3 | 12/03/2024 |
5 | JANUS HENDERSON GROUP PLC Increases Stake in Benitec Biopharma Inc | 12/06/2024 |
6 | Acquisition by Boston Megan of 720000 shares of Benitec Biopharma at 12.18 subject to Rule 16b-3 | 12/09/2024 |
7 | Benitec Biopharma stock soars to 52-week high of 13.29 - Investing.com | 12/17/2024 |
8 | Acquisition by Suvretta Capital Management, Llc of 3142 shares of Benitec Biopharma at 10.98 subject to Rule 16b-3 | 12/23/2024 |
9 | Acquisition by Suvretta Capital Management, Llc of 2288 shares of Benitec Biopharma at 11.25 subject to Rule 16b-3 | 12/24/2024 |
10 | Acquisition by Suvretta Capital Management, Llc of 24360 shares of Benitec Biopharma at 10.98 subject to Rule 16b-3 | 12/26/2024 |
11 | Insider Trading | 12/31/2024 |
12 | Why You Shouldnt Bet Against Benitec Biopharma Stock | 01/13/2025 |
13 | Benitec Biopharma Announces Three Major Conference Presentations for Early 2025 - StockTitan | 01/27/2025 |
About Benitec Biopharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Benitec or other stocks. Alpha measures the amount that position in Benitec Biopharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | Days Sales Outstanding | 445.01 | 524.32 | PTB Ratio | 0.56 | 0.53 |
Benitec Biopharma Upcoming Company Events
As portrayed in its financial statements, the presentation of Benitec Biopharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Benitec Biopharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Benitec Biopharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Benitec Biopharma. Please utilize our Beneish M Score to check the likelihood of Benitec Biopharma's management manipulating its earnings.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Benitec Biopharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Benitec Biopharma Backtesting, Benitec Biopharma Valuation, Benitec Biopharma Correlation, Benitec Biopharma Hype Analysis, Benitec Biopharma Volatility, Benitec Biopharma History and analyze Benitec Biopharma Performance. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Benitec Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.